SEC Form 4 · accession 0001179110-16-024907
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Staffieri
Officer — COO, Kidney Care
Period of report
May 13, 2016
Accepted (ET)
May 17, 2016 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 16, 2016 | S | 4,934 | $75.6884 | D | 12,279 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF3 | $75.42 | May 13, 2016 | A | 66,477 | A | May 13, 2019 | May 13, 2021 | Common Stock | 66,477 | 66,477 | D |
Explanation of responses
- F1Represents the weighted average sale price of $75.6884. The range of prices for the sale of these shares was $75.22 - $75.91, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F2This amount includes 330 shares acquired under Issuer's employee stock purchase plan on 12/31/2015.
- F3The Stock Appreciation Rights were granted on 5/13/2016. 50% will vest on 5/13/2019 and the remaining 50% will vest on 5/13/2020.